PillLifitegrast
Brands: Xiidra · Lifitegrast
2 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | unknown | 2 | SUPPLYING |
| Bausch & Lomb Incorporated | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- May 10, 2022RECALLRecall (Class III): Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vi…
Failed Impurities/Degradation Specifications. — Recalling firm: Novartis Pharmaceuticals Corporation — Nationwide within the United States
- May 10, 2022RECALLRecall (Class III): Xiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers…
Failed Impurities/Degradation Specifications. — Recalling firm: Novartis Pharmaceuticals Corporation — Nationwide within the United States